Skip to main content
UniHealth

Doctor search

Jeffrey E Dunn, MD

Neurology · Stanford

NPI 1639123383

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dunn’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G88167 · Current

Licensed to practise in California · since 2007 · expires 2027-11-30 · Temple University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$21,785

Medicare paid this office $21,785 for 100 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)54$10,969$161
Long return visit (40+ min)52$7,257$123

Who their Medicare patients are

100 Original Medicare patients in 2024. Average age 66 · Under 65 30% · Women 78% · Also on Medicaid 18% · Health risk score 1.64. Above the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 48% · Depression 24% · Diabetes 15% · Coronary heart disease 12% · Cancer 12% · COPD 12%.

The office billed $92,253, Medicare allowed $29,484 and paid $21,785; for 171 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024100171661.64$92,253$21,785
2023116185651.54$84,636$20,105
2022123184661.53$77,832$19,206
2021113205641.34$89,944$22,548
2020109187631.40$76,244$14,017
2019117183641.41$32,949$16,594
201894135621.42$20,588$12,046
2017102158621.35$35,059$14,566
2016101157621.44$40,510$12,294
2015115194631.56$58,280$17,465
201497166621.29$48,136$14,757
201377119611.34$34,154$9,970

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)87$15,847$120
Return visit (30+ min)17$1,673$76

2022: 3 services

Original Medicare services billed in 2022
Long return visit (40+ min)81$13,211$116
Return visit (30+ min)27$2,551$80
New patient visit (60+ min)13$1,594$123

2021: 3 services

Original Medicare services billed in 2021
Long return visit (40+ min)79$14,368$119
Return visit (30+ min)35$3,699$79
New patient visit (60+ min)19$3,336$176

2020: 3 services

Original Medicare services billed in 2020
Long return visit (40+ min)62$6,890$84
Return visit (30+ min)44$3,783$64
Telephone medical discussion with physician, 21-30 minutes15$1,217$72

2019: 3 services

Original Medicare services billed in 2019
Long return visit (40+ min)94$11,799$89
New patient visit (60+ min)19$2,710$143
Return visit (30+ min)20$1,507$69

2018: 3 services

Original Medicare services billed in 2018
Long return visit (40+ min)61$5,507$80
Long return visit (40+ min)35$3,749$99
New patient visit (60+ min)14$2,066$148

2017: 3 services

Original Medicare services billed in 2017
Long return visit (40+ min)75$8,962$91
New patient visit (60+ min)21$3,152$150
Return visit (30+ min)31$2,452$63

2016: 3 services

Original Medicare services billed in 2016
Long return visit (40+ min)40$4,665$86
Return visit (30+ min)56$4,361$61
New patient visit (60+ min)22$2,661$121

2015: 4 services

Original Medicare services billed in 2015
Long return visit (40+ min)50$5,688$93
New patient visit (60+ min)27$3,482$129
Return visit (30+ min)39$3,479$63
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,590$122

2014: 3 services

Original Medicare services billed in 2014
Long return visit (40+ min)36$3,947$96
Return visit (30+ min)36$2,941$57
New patient visit (60+ min)20$2,849$142

2013: 2 services

Original Medicare services billed in 2013
Return visit (30+ min)42$3,268$56
New patient visit (60+ min)16$2,202$138

Drugs they prescribed that Part D paid

$610,243

Pharmacies billed $610,243 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 4% of their Part D prescriptions (11 of 250) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%. Long-acting opioids: 100% of their opioid prescriptions.

188 generic and 62 brand-name prescriptions · $610,243 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Vumerity25$211,457$8,458
Dalfampridine Er37$14,555$393
Tramadol Hcl Er11$949$86
Baclofen31$792$26
Gabapentin17$303$18
See all 7 drugs
Every Part D drug this clinician prescribed
Vumerity25$211,457$8,458
Dalfampridine Er37$14,555$393
Tramadol Hcl Er11$949$86
Baclofen31$792$26
Gabapentin17$303$18
Tizanidine12$196$16
Pramipexole Dihydrochloride16$39$2

Year by year

Part D prescribing by year
2024250454% (11)25%$610,243
202325049None22%$555,119
202224946None19%$493,420
202128350None35%$891,617
202031251None33%$942,564
2019288530% (0)39%$887,412
201824548None49%$1,000,469
2017282580% (0)55%$1,030,868
2016283490% (0)59%$862,868
2015205400% (0)77%$665,798
2014153310% (0)73%$579,663
2013158320% (0)73%$537,242

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Part D drugs prescribed in 2023
Gamunex-CImmune globulin12$235,846$19,654
VumerityNone12$99,544$8,295
Dalfampridine ErNone40$25,428$636
BaclofenNone15$797$53
GabapentinNone16$574$36
TizanidineNone12$482$40
AcyclovirNone13$274$21
Pramipexole DihydrochlorideNone11$97$9

2022: 7 drugs

Part D drugs prescribed in 2022
Tecfidera13$119,190$9,168
Dalfampridine Er43$22,803$530
Dimethyl21$11,408$543
Modafinil18$4,683$260
Baclofen17$1,577$93
Tizanidine19$702$37
Gabapentin15$640$43

2021: 9 drugs

Part D drugs prescribed in 2021
Tecfidera28$246,082$8,789
Gilenya13$128,931$9,918
Aubagio11$81,382$7,398
Glatiramer Acetate12$56,630$4,719
Dimethyl19$30,957$1,629
Dalfampridine Er47$17,341$369
Modafinil22$5,608$255
Baclofen16$1,564$98
Pregabalin14$1,028$73

2020: 10 drugs

Part D drugs prescribed in 2020
Tecfidera36$355,582$9,877
Gilenya12$112,453$9,371
Glatiramer Acetate12$81,824$6,819
Copaxone15$67,919$4,528
Dalfampridine Er32$31,862$996
Modafinil39$9,459$243
Pregabalin15$964$64
Baclofen16$827$52
Gabapentin16$492$31
Sertraline12$90$7

2019: 10 drugs

Part D drugs prescribed in 2019
Tecfidera40$333,396$8,335
Glatiramer Acetate14$65,442$4,674
Ampyra17$50,456$2,968
Dalfampridine Er26$35,853$1,379
Modafinil29$8,438$291
Lyrica11$7,760$705
Gabapentin14$595$42
Baclofen13$305$23
Acyclovir13$188$14
Ibuprofen12$50$4

2018: 6 drugs

Part D drugs prescribed in 2018
Tecfidera65$616,042$9,478
Glatiramer Acetate15$56,174$3,745
Ampyra19$52,274$2,751
Baclofen26$927$36
Gabapentin14$437$31
Tizanidine11$79$7

2017: 9 drugs

Part D drugs prescribed in 2017
Tecfidera48$403,879$8,414
Copaxone22$168,301$7,650
Avonex18$113,545$6,308
Aubagio15$88,968$5,931
Ampyra31$71,558$2,308
Modafinil11$4,702$427
Gabapentin22$654$30
Tizanidine16$565$35
Baclofen14$449$32

2016: 6 drugs

Part D drugs prescribed in 2016
Tecfidera54$334,853$6,201
Aubagio28$163,326$5,833
Copaxone28$154,539$5,519
Ampyra36$71,836$1,995
Gabapentin20$716$36
Baclofen18$588$33

2015: 3 drugs

Part D drugs prescribed in 2015
Copaxone45$229,640$5,103
Tecfidera38$216,540$5,698
Ampyra46$88,940$1,933

2014: 3 drugs

Part D drugs prescribed in 2014
Tecfidera47$255,555$5,437
Copaxone42$203,700$4,850
Gabapentin12$135$11

2013: 4 drugs

Part D drugs prescribed in 2013
Tecfidera59$281,493$4,771
Copaxone24$116,188$4,841
Ampyra14$21,102$1,507
Baclofen22$307$14

Money from drug and device companies

$30,054 in 2025

Industry payments by year
2025423$23,903$30,054
2024922$21,131$25,155
20231146$45,728$50,144
20221179$64,193$81,537
20211024$44,920$45,372
2020532$44,313$45,566
20197164$130,975$159,285

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Genentech USAOcrevus$24,090
19 payments
  • Meals · 2025-12-05 · $66
  • Travel · 2025-12-05 · $250
  • Meals · 2025-12-05 · $52
  • Meals · 2025-12-05 · $222
  • Travel · 2025-12-05 · $2,837
  • Travel · 2025-12-05 · $107
  • Meals · 2025-12-05 · $81
  • Consulting · 2025-12-05 · $6,525
  • Meals · 2025-06-13 · $19
  • Meals · 2025-06-13 · $74
  • Consulting · 2025-06-13 · $5,075
  • Meals · 2025-06-13 · $80
  • Travel for Ocrevus · 2025-04-25 · $1,622
  • Travel for Ocrevus · 2025-04-25 · $74
  • Meals for Ocrevus · 2025-04-25 · $74
  • Meals for Ocrevus · 2025-04-25 · $74
  • Meals for Ocrevus · 2025-04-25 · $96
  • Consulting for Ocrevus · 2025-04-25 · $6,525
  • Travel for Ocrevus · 2025-04-25 · $238
AstraZeneca Pharmaceuticals LPNone$4,375
1 payment
  • Consulting · 2025-12-17 · $4,375
GenzymeNone$1,403
1 payment
  • Consulting · 2025-02-14 · $1,403
TG TherapeuticsBriumvi$185
2 payments
  • Meals for Briumvi · 2025-02-26 · $111
  • Meals for Briumvi · 2025-01-16 · $74
See all 23 published payments
Every published payment
AstraZeneca Pharmaceuticals LPConsulting · 2025-12-17None$4,375
Genentech USAMeals · 2025-12-05None$66
Genentech USATravel · 2025-12-05None$250
Genentech USAMeals · 2025-12-05None$52
Genentech USAMeals · 2025-12-05None$222
Genentech USATravel · 2025-12-05None$2,837
Genentech USATravel · 2025-12-05None$107
Genentech USAMeals · 2025-12-05None$81
Genentech USAConsulting · 2025-12-05None$6,525
Genentech USAMeals · 2025-06-13None$19
Genentech USAMeals · 2025-06-13None$74
Genentech USAConsulting · 2025-06-13None$5,075
Genentech USAMeals · 2025-06-13None$80
Genentech USATravel · 2025-04-25Ocrevus$1,622
Genentech USATravel · 2025-04-25Ocrevus$74
Genentech USAMeals · 2025-04-25Ocrevus$74
Genentech USAMeals · 2025-04-25Ocrevus$74
Genentech USAMeals · 2025-04-25Ocrevus$96
Genentech USAConsulting · 2025-04-25Ocrevus$6,525
Genentech USATravel · 2025-04-25Ocrevus$238
TG TherapeuticsMeals · 2025-02-26Briumvi$111
GenzymeConsulting · 2025-02-14None$1,403
TG TherapeuticsMeals · 2025-01-16Briumvi$74
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $25,155

Payments by company in 2024
Genentech USAOcrevus$15,019
10 payments
  • Consulting for Ocrevus · 2024-10-26 · $6,210
  • Meals for Ocrevus · 2024-10-26 · $64
  • Travel for Ocrevus · 2024-10-26 · $216
  • Travel for Ocrevus · 2024-10-26 · $2,504
  • Meals for Ocrevus · 2024-10-26 · $109
  • Meals for Ocrevus · 2024-10-26 · $84
  • Travel for Ocrevus · 2024-10-26 · $76
  • Consulting for Ocrevus · 2024-03-09 · $5,520
  • Travel for Ocrevus · 2024-03-09 · $77
  • Meals for Enspryng · 2024-01-18 · $158
Vanda PharmaceuticalsPonvory$4,025
1 payment
  • Paid to speak or teach for Ponvory · 2024-09-23 · $4,025
GenzymeDupixent$3,726
2 payments
  • Consulting · 2024-11-27 · $2,176
  • Consulting for Dupixent · 2024-11-27 · $1,550
AmgenUplizna$1,774
3 payments
  • Paid to speak or teach for Uplizna · 2024-03-20 · $825
  • Meals for Uplizna · 2024-02-08 · $124
  • Paid to speak or teach for Uplizna · 2024-01-11 · $825
TG TherapeuticsBriumvi$216
2 payments
  • Meals for Briumvi · 2024-07-01 · $171
  • Meals for Briumvi · 2024-02-29 · $45
EMD SeronoNone$121
1 payment
  • Meals · 2024-03-13 · $121
Novartis PharmaceuticalsKesimpta$115
1 payment
  • Meals for Kesimpta · 2024-06-27 · $115
CelgeneZeposia$95
1 payment
  • Meals for Zeposia · 2024-11-20 · $95
Alexion PharmaceuticalsUltomiris$64
1 payment
  • Meals for Ultomiris · 2024-04-15 · $64

2023: $50,144

Payments by company in 2023
EMD SeronoEvobrutinib$17,550
12 payments
  • Consulting for Evobrutinib · 2023-10-10 · $3,128
  • Consulting · 2023-10-10 · $13,205
  • Meals · 2023-09-10 · $26
  • Meals · 2023-09-10 · $52
  • Travel · 2023-09-10 · $603
  • Meals · 2023-09-09 · $52
  • Meals · 2023-09-09 · $67
  • Meals · 2023-09-09 · $129
  • Meals · 2023-09-09 · $26
  • Meals · 2023-09-09 · $26
  • Meals · 2023-09-08 · $129
  • Meals for Mavenclad · 2023-02-23 · $107
Horizon Therapeutics plcUplizna$15,732
17 payments
  • Honoraria for Uplizna · 2023-12-30 · $200
  • Honoraria for Uplizna · 2023-12-28 · $825
  • Travel for Uplizna · 2023-11-04 · $807
  • Travel for Uplizna · 2023-11-04 · $350
  • Travel for Uplizna · 2023-11-04 · $181
  • Meals for Uplizna · 2023-11-04 · $49
  • Meals for Uplizna · 2023-11-04 · $25
  • Meals for Uplizna · 2023-11-04 · $64
  • Meals for Uplizna · 2023-11-04 · $25
  • Travel for Uplizna · 2023-11-04 · $137
  • Honoraria for Uplizna · 2023-11-04 · $9,350
  • Meals for Uplizna · 2023-11-03 · $125
  • Meals for Uplizna · 2023-08-30 · $43
  • Honoraria for Uplizna · 2023-08-17 · $2,750
  • Honoraria for Uplizna · 2023-07-11 · $200
  • Honoraria for Uplizna · 2023-05-24 · $200
  • Honoraria for Uplizna · 2023-02-24 · $400
Genentech USAOcrevus$7,229
5 payments
  • Consulting for Ocrevus · 2023-11-02 · $6,210
  • Travel for Ocrevus · 2023-11-02 · $759
  • Meals for Ocrevus · 2023-11-02 · $30
  • Travel for Ocrevus · 2023-11-02 · $198
  • Meals for Enspryng · 2023-02-24 · $31
Alexion PharmaceuticalsSoliris$4,260
2 payments
  • Paid to speak or teach for Soliris · 2023-12-07 · $2,130
  • Paid to speak or teach for Ultomiris · 2023-03-21 · $2,130
TG TherapeuticsBriumvi$3,200
4 payments
  • Paid to speak or teach for Briumvi · 2023-06-16 · $1,200
  • Consulting for Briumvi · 2023-05-08 · $600
  • Paid to speak or teach for Briumvi · 2023-03-22 · $1,200
  • Paid to speak or teach for Briumvi · 2023-03-16 · $200
Janssen PharmaceuticalsPonvory$1,800
1 payment
  • Paid to speak or teach for Ponvory · 2023-02-01 · $1,800
Novartis PharmaceuticalsKesimpta$129
1 payment
  • Meals for Kesimpta · 2023-04-04 · $129
CelgeneZeposia$105
1 payment
  • Meals for Zeposia · 2023-02-15 · $105
GenzymeNone$85
1 payment
  • Meals · 2023-02-22 · $85
MylanNone$31
1 payment
  • Meals · 2023-02-22 · $31
Banner Life SciencesBafiertam$24
1 payment
  • Meals for Bafiertam · 2023-10-04 · $24

2022: $81,537

Payments by company in 2022
Horizon Therapeutics plcUplizna$20,106
15 payments
  • Meals for Uplizna · 2022-12-16 · $65
  • Meals for Uplizna · 2022-10-08 · $27
  • Travel for Uplizna · 2022-10-08 · $930
  • Travel for Uplizna · 2022-10-08 · $348
  • Meals for Uplizna · 2022-10-08 · $48
  • Meals for Uplizna · 2022-10-08 · $24
  • Meals for Uplizna · 2022-10-08 · $24
  • Meals for Uplizna · 2022-10-08 · $62
  • Honoraria for Uplizna · 2022-10-08 · $8,000
  • Meals for Uplizna · 2022-10-07 · $110
  • Honoraria for Uplizna · 2022-10-01 · $7,075
  • Travel for Uplizna · 2022-10-01 · $1,991
  • Travel for Uplizna · 2022-10-01 · $1,053
  • Travel for Uplizna · 2022-10-01 · $225
  • Meals for Uplizna · 2022-02-05 · $125
Genentech USAOcrevus$16,535
13 payments
  • Meals for Enspryng · 2022-11-29 · $135
  • Travel for Enspryng · 2022-11-09 · $50
  • Paid to speak or teach for Enspryng · 2022-11-09 · $3,000
  • Meals for Ocrevus · 2022-07-09 · $205
  • Travel for Ocrevus · 2022-07-08 · $41
  • Meals for Ocrevus · 2022-07-08 · $205
  • Travel for Ocrevus · 2022-07-08 · $348
  • Consulting for Ocrevus · 2022-07-08 · $5,520
  • Travel for Ocrevus · 2022-07-07 · $235
  • Meals for Ocrevus · 2022-07-07 · $120
  • Paid to speak or teach for Ocrevus · 2022-07-07 · $4,800
  • Meals for Ocrevus · 2022-04-04 · $75
  • Consulting for Ocrevus · 2022-03-29 · $1,800
E.R. Squibb & Sons L.L.C.Zeposia$13,410
11 payments
  • Travel · 2022-12-12 · $1,539
  • Consulting · 2022-11-17 · $4,610
  • Travel · 2022-11-03 · $163
  • Meals · 2022-11-01 · $43
  • Meals · 2022-11-01 · $24
  • Meals · 2022-11-01 · $59
  • Meals · 2022-11-01 · $30
  • Consulting for Zeposia · 2022-08-18 · $2,480
  • Meals · 2022-07-06 · $22
  • Consulting · 2022-06-27 · $4,340
  • Meals for Zeposia · 2022-04-06 · $100
TG TherapeuticsNone$6,976
9 payments
  • Travel · 2022-04-30 · $55
  • Paid to speak or teach · 2022-04-30 · $3,400
  • Meals · 2022-04-30 · $48
  • Meals · 2022-04-30 · $37
  • Meals · 2022-04-30 · $59
  • Travel · 2022-04-29 · $301
  • Travel · 2022-04-29 · $2,945
  • Travel · 2022-04-29 · $124
  • Meals · 2022-04-04 · $7
Janssen PharmaceuticalsPonvory$6,791
6 payments
  • Meals for Ponvory · 2022-08-04 · $125
  • Meals for Ponvory · 2022-08-04 · $79
  • Paid to speak or teach for Ponvory · 2022-08-03 · $2,790
  • Paid to speak or teach for Ponvory · 2022-06-01 · $2,790
  • Meals for Ponvory · 2022-05-11 · $123
  • Travel for Ponvory · 2022-05-11 · $883
Alexion PharmaceuticalsSoliris$5,489
6 payments
  • Paid to speak or teach for Soliris · 2022-12-06 · $1,020
  • Paid to speak or teach for Soliris · 2022-11-22 · $2,550
  • Education for Soliris · 2022-11-08 · $10
  • Meals for Soliris · 2022-11-08 · $124
  • Paid to speak or teach for Soliris · 2022-05-11 · $255
  • Paid to speak or teach for Soliris · 2022-03-17 · $1,530
GenzymeNone$5,091
3 payments
  • Consulting · 2022-12-01 · $3,504
  • Consulting · 2022-12-01 · $1,460
  • Meals · 2022-09-24 · $127
BiogenTysabri$3,517
4 payments
  • Consulting · 2022-09-13 · $358
  • Consulting · 2022-07-19 · $2,912
  • Meals for Tysabri · 2022-05-26 · $130
  • Meals for Tysabri · 2022-04-06 · $117
CelgeneZeposia$3,378
9 payments
  • Meals for Zeposia · 2022-10-05 · $25
  • Meals for Zeposia · 2022-06-10 · $125
  • Travel for Zeposia · 2022-06-10 · $2,748
  • Travel for Zeposia · 2022-06-10 · $304
  • Meals for Zeposia · 2022-06-10 · $30
  • Meals for Zeposia · 2022-06-10 · $30
  • Meals for Zeposia · 2022-06-10 · $60
  • Meals for Zeposia · 2022-06-10 · $50
  • Meals for Zeposia · 2022-04-03 · $6
Janssen Scientific AffairsPonvory$142
1 payment
  • Meals for Ponvory · 2022-11-17 · $142
Novartis PharmaceuticalsKesimpta$102
2 payments
  • Meals for Kesimpta · 2022-07-20 · $40
  • Meals · 2022-04-05 · $62

2021: $45,372

Payments by company in 2021
GenzymeAubagio$10,735
3 payments
  • Paid to speak or teach · 2021-10-06 · $2,373
  • Consulting for Aubagio · 2021-05-05 · $5,650
  • Paid to speak or teach · 2021-03-30 · $2,712
Alexion PharmaceuticalsSoliris$7,262
4 payments
  • Consulting for Soliris · 2021-11-03 · $3,825
  • Paid to speak or teach for Soliris · 2021-10-05 · $2,295
  • Meals for Soliris · 2021-09-30 · $122
  • Paid to speak or teach for Soliris · 2021-02-25 · $1,020
CelgeneZeposia$7,120
2 payments
  • Paid to speak or teach for Zeposia · 2021-03-28 · $300
  • Paid to speak or teach for Zeposia · 2021-03-08 · $6,820
Genentech USAOcrevus$7,095
4 payments
  • Paid to speak or teach for Ocrevus · 2021-11-29 · $1,800
  • Consulting for Ocrevus · 2021-11-02 · $1,800
  • Consulting for Ocrevus · 2021-05-13 · $900
  • Consulting for Ocrevus · 2021-03-11 · $2,595
Janssen PharmaceuticalsPonvory$3,968
3 payments
  • Paid to speak or teach for Ponvory · 2021-12-08 · $375
  • Paid to speak or teach · 2021-11-08 · $3,510
  • Meals · 2021-09-29 · $83
E.R. Squibb & Sons L.L.C.Zeposia$3,950
2 payments
  • Consulting · 2021-12-02 · $2,400
  • Paid to speak or teach for Zeposia · 2021-11-17 · $1,550
Horizon Therapeutics plcUplizna$3,250
2 payments
  • Honoraria for Uplizna · 2021-08-04 · $2,000
  • Honoraria for Uplizna · 2021-06-09 · $1,250
Janssen Scientific AffairsPonvory$945
1 payment
  • Consulting for Ponvory · 2021-12-08 · $945
Banner Life SciencesBafiertam$800
1 payment
  • Honoraria for Bafiertam · 2021-06-07 · $800
BiogenNone$248
2 payments
  • Meals · 2021-09-30 · $125
  • Meals · 2021-06-17 · $123

2020: $45,566

Payments by company in 2020
CelgeneZeposia$18,786
18 payments
  • Paid to speak or teach for Zeposia · 2020-06-28 · $2,170
  • Paid to speak or teach for Zeposia · 2020-06-22 · $2,170
  • Consulting for Zeposia · 2020-06-18 · $1,860
  • Paid to speak or teach for Zeposia · 2020-06-17 · $2,170
  • Paid to speak or teach for Zeposia · 2020-05-04 · $620
  • Consulting for Zeposia · 2020-04-22 · $1,860
  • Travel for Zeposia · 2020-02-22 · $426
  • Travel for Zeposia · 2020-02-22 · $260
  • Paid to speak or teach for Zeposia · 2020-02-22 · $4,650
  • Meals for Zeposia · 2020-02-22 · $60
  • Meals for Zeposia · 2020-02-22 · $29
  • Meals for Zeposia · 2020-02-22 · $8
  • Meals for Zeposia · 2020-02-22 · $50
  • Meals for Zeposia · 2020-02-22 · $125
  • Meals for Zeposia · 2020-02-22 · $60
  • Travel for Zeposia · 2020-02-22 · $72
  • Travel for Zeposia · 2020-02-22 · $25
  • Paid to speak or teach for Zeposia · 2020-01-20 · $2,170
Alexion PharmaceuticalsSoliris$9,812
8 payments
  • Paid to speak or teach for Soliris · 2020-11-20 · $1,530
  • Paid to speak or teach for Soliris · 2020-07-28 · $1,530
  • Consulting for Soliris · 2020-05-20 · $4,335
  • Paid to speak or teach for Soliris · 2020-05-12 · $1,530
  • Meals for Soliris · 2020-02-28 · $83
  • Travel · 2020-01-16 · $5
  • Travel · 2020-01-16 · $49
  • Paid to speak or teach · 2020-01-14 · $750
Genentech USAOcrevus$8,298
4 payments
  • Paid to speak or teach for Ocrevus · 2020-11-04 · $1,800
  • Paid to speak or teach for Enspryng · 2020-10-28 · $1,800
  • Paid to speak or teach for Ocrevus · 2020-07-01 · $1,800
  • Consulting for Ocrevus · 2020-05-16 · $2,898
BiogenNone$7,350
1 payment
  • Consulting · 2020-01-13 · $7,350
Janssen Scientific AffairsNone$1,320
1 payment
  • Consulting · 2020-12-09 · $1,320

2019: $159,285

Payments by company in 2019
Alexion PharmaceuticalsSoliris$57,069
42 payments
  • Paid to speak or teach · 2019-12-17 · $3,315
  • Meals · 2019-12-11 · $122
  • Meals for Soliris · 2019-12-10 · $20
  • Travel for Soliris · 2019-12-10 · $117
  • Paid to speak or teach · 2019-12-03 · $3,315
  • Paid to speak or teach for Soliris · 2019-11-21 · $3,565
  • Meals · 2019-11-20 · $111
  • Paid to speak or teach for Soliris · 2019-11-15 · $3,315
  • Travel · 2019-11-14 · $380
  • Consulting · 2019-11-14 · $6,120
  • Travel · 2019-11-14 · $10,340
  • Travel · 2019-11-14 · $527
  • Meals for Soliris · 2019-11-06 · $101
  • Travel for Soliris · 2019-09-17 · $42
  • Paid to speak or teach for Soliris · 2019-09-03 · $3,315
  • Meals for Soliris · 2019-08-29 · $121
  • Paid to speak or teach for Soliris · 2019-08-27 · $3,315
  • Meals for Soliris · 2019-08-22 · $125
  • Meals · 2019-07-13 · $15
  • Meals · 2019-07-13 · $25
  • Meals · 2019-07-13 · $35
  • Meals · 2019-07-13 · $50
  • Paid to speak or teach · 2019-07-13 · $4,335
  • Meals · 2019-07-12 · $125
  • Travel · 2019-07-12 · $271
  • Travel · 2019-07-12 · $571
  • Consulting · 2019-07-12 · $28
  • Consulting · 2019-07-12 · $72
  • Paid to speak or teach · 2019-06-18 · $3,315
  • Meals · 2019-05-22 · $125
  • Meals · 2019-05-08 · $67
  • Meals · 2019-04-27 · $25
  • Meals · 2019-04-27 · $35
  • Meals · 2019-04-27 · $47
  • Meals · 2019-04-27 · $50
  • Travel · 2019-04-27 · $58
  • Paid to speak or teach · 2019-04-27 · $8,160
  • Meals · 2019-04-26 · $21
  • Meals · 2019-04-26 · $125
  • Travel · 2019-04-26 · $187
  • Travel · 2019-04-26 · $218
  • Travel · 2019-04-26 · $844
GenzymeLemtrada$40,981
46 payments
  • Paid to speak or teach for Lemtrada · 2019-12-18 · $2,940
  • Travel for Lemtrada · 2019-12-18 · $49
  • Meals for Lemtrada · 2019-12-18 · $60
  • Travel for Lemtrada · 2019-10-23 · $133
  • Travel for Lemtrada · 2019-10-23 · $370
  • Travel for Lemtrada · 2019-10-23 · $69
  • Paid to speak or teach for Lemtrada · 2019-10-23 · $2,450
  • Travel for Lemtrada · 2019-10-23 · $133
  • Travel for Lemtrada · 2019-10-23 · $370
  • Travel for Lemtrada · 2019-10-23 · $69
  • Paid to speak or teach for Lemtrada · 2019-10-23 · $2,450
  • Paid to speak or teach for Lemtrada · 2019-10-22 · $5,390
  • Travel for Lemtrada · 2019-10-22 · $370
  • Travel for Lemtrada · 2019-10-22 · $83
  • Paid to speak or teach for Lemtrada · 2019-10-22 · $2,450
  • Travel for Lemtrada · 2019-10-22 · $133
  • Travel for Lemtrada · 2019-10-22 · $370
  • Travel for Lemtrada · 2019-10-22 · $69
  • Paid to speak or teach for Lemtrada · 2019-10-22 · $2,450
  • Travel for Lemtrada · 2019-10-22 · $57
  • Travel for Lemtrada · 2019-10-22 · $370
  • Travel for Lemtrada · 2019-10-22 · $69
  • Meals for Lemtrada · 2019-10-22 · $110
  • Travel for Lemtrada · 2019-10-22 · $161
  • Meals for Lemtrada · 2019-10-16 · $106
  • Paid to speak or teach for Lemtrada · 2019-10-16 · $2,450
  • Meals for Lemtrada · 2019-10-16 · $9
  • Travel for Lemtrada · 2019-10-16 · $215
  • Paid to speak or teach for Lemtrada · 2019-10-16 · $4,410
  • Paid to speak or teach for Lemtrada · 2019-06-19 · $3,185
  • Travel for Lemtrada · 2019-06-19 · $57
  • Travel for Lemtrada · 2019-06-19 · $7
  • Paid to speak or teach for Lemtrada · 2019-04-03 · $3,675
  • Travel for Lemtrada · 2019-04-03 · $549
  • Meals for Lemtrada · 2019-04-03 · $58
  • Travel for Lemtrada · 2019-02-08 · $426
  • Travel for Lemtrada · 2019-02-08 · $248
  • Meals for Lemtrada · 2019-02-08 · $140
  • Meals for Lemtrada · 2019-02-08 · $46
  • Meals for Lemtrada · 2019-02-08 · $52
  • Meals for Lemtrada · 2019-02-08 · $65
  • Paid to speak or teach for Lemtrada · 2019-02-08 · $3,798
  • Travel for Lemtrada · 2019-02-08 · $72
  • Travel for Lemtrada · 2019-02-08 · $26
  • Travel for Lemtrada · 2019-02-08 · $118
  • Travel for Lemtrada · 2019-02-08 · $96
BiogenTysabri$19,446
29 payments
  • Meals · 2019-11-23 · $56
  • Meals · 2019-11-23 · $56
  • Meals · 2019-11-23 · $105
  • Travel · 2019-11-23 · $72
  • Travel · 2019-11-23 · $26
  • Travel · 2019-11-23 · $46
  • Meals · 2019-11-22 · $123
  • Meals · 2019-11-22 · $60
  • Consulting · 2019-11-22 · $7,613
  • Travel · 2019-11-22 · $229
  • Travel · 2019-11-22 · $897
  • Travel · 2019-11-22 · $188
  • Travel · 2019-09-07 · $98
  • Meals · 2019-09-07 · $35
  • Meals · 2019-09-07 · $44
  • Meals · 2019-09-07 · $55
  • Travel · 2019-09-06 · $193
  • Travel · 2019-09-06 · $351
  • Meals · 2019-09-06 · $123
  • Consulting · 2019-07-26 · $7,875
  • Travel · 2019-07-22 · $28
  • Travel · 2019-07-22 · $72
  • Meals · 2019-07-19 · $84
  • Meals · 2019-07-19 · $67
  • Meals · 2019-07-19 · $57
  • Meals · 2019-07-18 · $135
  • Travel · 2019-07-18 · $281
  • Travel · 2019-07-18 · $353
  • Meals for Tysabri · 2019-06-06 · $125
Novartis PharmaceuticalsMayzent$14,089
18 payments
  • Paid to speak or teach for Mayzent · 2019-12-09 · $2,660
  • Meals for Mayzent · 2019-12-09 · $113
  • Travel for Mayzent · 2019-07-16 · $44
  • Paid to speak or teach for Mayzent · 2019-07-16 · $2,660
  • Meals for Mayzent · 2019-07-16 · $114
  • Travel for Mayzent · 2019-07-15 · $58
  • Paid to speak or teach for Mayzent · 2019-07-15 · $2,660
  • Meals for Mayzent · 2019-07-15 · $131
  • Travel · 2019-06-08 · $148
  • Travel · 2019-06-08 · $172
  • Paid to speak or teach · 2019-06-08 · $1,750
  • Meals · 2019-06-08 · $135
  • Travel · 2019-06-08 · $72
  • Meals · 2019-06-07 · $115
  • Travel · 2019-06-07 · $418
  • Meals for Mayzent · 2019-04-16 · $98
  • Paid to speak or teach for Gilenya · 2019-03-20 · $2,660
  • Meals for Gilenya · 2019-01-23 · $81
CelgeneOzanimod$12,395
12 payments
  • Consulting for Ozanimod · 2019-12-19 · $620
  • Paid to speak or teach for Ozanimod · 2019-11-18 · $2,170
  • Paid to speak or teach for Ozanimod · 2019-11-11 · $2,170
  • Paid to speak or teach for Ozanimod · 2019-11-04 · $2,170
  • Meals for Ozanimod · 2019-06-14 · $21
  • Paid to speak or teach for Ozanimod · 2019-04-13 · $4,650
  • Travel for Ozanimod · 2019-04-13 · $69
  • Travel for Ozanimod · 2019-04-13 · $148
  • Meals for Ozanimod · 2019-04-13 · $36
  • Travel for Ozanimod · 2019-04-13 · $56
  • Travel for Ozanimod · 2019-04-13 · $146
  • Meals for Ozanimod · 2019-04-13 · $140
Genentech USAOcrevus$9,401
9 payments
  • Paid to speak or teach for Ocrevus · 2019-11-07 · $3,000
  • Travel for Ocrevus · 2019-11-07 · $27
  • Meals for Ocrevus · 2019-11-07 · $100
  • Paid to speak or teach for Ocrevus · 2019-10-02 · $3,000
  • Meals for Ocrevus · 2019-10-02 · $42
  • Paid to speak or teach for Ocrevus · 2019-08-07 · $3,000
  • Meals for Ocrevus · 2019-08-07 · $134
  • Travel for Ocrevus · 2019-08-07 · $42
  • Meals for Ocrevus · 2019-06-27 · $57
GenentechOcrevus$5,903
8 payments
  • Meals for Ocrevus · 2019-08-16 · $316
  • Travel for Ocrevus · 2019-08-15 · $106
  • Travel for Ocrevus · 2019-08-15 · $72
  • Meals for Ocrevus · 2019-08-15 · $121
  • Travel for Ocrevus · 2019-08-15 · $347
  • Meals for Ocrevus · 2019-08-15 · $8
  • Travel for Ocrevus · 2019-08-15 · $434
  • Consulting for Ocrevus · 2019-08-15 · $4,500

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Janssen Research & Development, LLC · Multicenter, Randomized, Double-Blind, Parallel-Group Extension Study Ac-058b201 To Investigate the Long-Term, Tolerability, and Efficacy of 10, 20, and 40 Mg/Day Act-129900, and Oral S1p1 Receptor Agonist, in Patients With Relapsing-Remitting Multiple Sclerosis · 2020Their institution$113,548
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2020Their institution$100,204
F. Hoffmann-La Roche AG · Roll Over Protocol for 3 Ocr Pivotal Studies Opera I Opera II and Oratorio To Extend the Ole · 2023Their institution$91,853
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2022Their institution$91,678
F. Hoffmann-La Roche AG · Roll Over Protocol for 3 Ocr Pivotal Studies Opera I Opera II and Oratorio To Extend the Ole · 2024Their institution$68,957
F. Hoffmann-La Roche AG · Roll Over Protocol for 3 Ocr Pivotal Studies Opera I Opera II and Oratorio To Extend the Ole · 2025Their institution$66,555
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2019Their institution$56,371
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2023Their institution$52,323
Janssen Research & Development, LLC · Multi Center Randomized Double Blind Parallel Group Extension Study Ac058b201 To Investigate the Long Term Tolerability and Efficacy of 10 20 and 40 Mg Day Act129900 and Oral S1p1 Receptor Agonist in Patients With Relapsing Remitting Multiple Sclerosis · 2021Their institution$47,873
Janssen Research & Development, LLC · Ms Phase 2 Extension Hq - Ac-058b202 · 2019Their institution$29,152
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2021Their institution$14,790
Janssen Research & Development, LLC · Multi Center Randomized Double Blind Parallel Group Extension Study Ac058b201 To Investigate the Long Term Tolerability and Efficacy of 10 20 and 40 Mg Day Act129900 and Oral S1p1 Receptor Agonist in Patients With Relapsing Remitting Multiple Sclerosis · 2022Their institution$5,475
F. Hoffmann-La Roche AG · Second Phase III in Rms · 2024Their institution$1,600

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1639123383
Licence
CA G88167California G88167: Current · expires 2027-11-30
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X); Federal specialty code 2084N0008X (2084N0008X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-05-19
NPI last updated
2023-11-07
NPI record certified
2023-11-07

This is when the NPI record was last certified, not a medical board exam.